<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>7</volume><submitter>Tan J</submitter><pubmed_abstract>&lt;b>Background:&lt;/b> This study was aimed at investigating the clinical significance and curative effect of global glomerulosclerosis (GS) and segmental glomerulosclerosis (S) in adult-onset IgA vasculitis with nephritis (IgAV-N) patients since there was no consensus pathological grading method for adult IgAV-N. &lt;b>Methods:&lt;/b> A total of 188 biopsy-proven IgAV-N patients were prospectively identified. Patients were separately assigned to GS0/GS1/GS2 group and S0/S1/S2 based on the scores of global glomerulosclerosis and segmental glomerulosclerosis (0% /0-15% />15%, respectively). &lt;b>Results:&lt;/b> GS0, GS1, and GS2 occurred in 56.4, 29.2, and 14.4% of the adult-onset IgAV-N, respectively. Patients in GS2 group tended to have the most serious renal deterioration and the highest levels of bloo</pubmed_abstract><journal>Frontiers in medicine</journal><pagination>588031</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7646400</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Global Glomerulosclerosis and Segmental Glomerulosclerosis Could Serve as Effective Markers for Prognosis and Treatment of IgA Vasculitis With Nephritis.</pubmed_title><pmcid>PMC7646400</pmcid><pubmed_authors>Tan L</pubmed_authors><pubmed_authors>Tarun P</pubmed_authors><pubmed_authors>Jiang Z</pubmed_authors><pubmed_authors>Tan J</pubmed_authors><pubmed_authors>Qin W</pubmed_authors><pubmed_authors>Zhong Z</pubmed_authors><pubmed_authors>Pei G</pubmed_authors><pubmed_authors>Tang Y</pubmed_authors><pubmed_authors>Xu Y</pubmed_authors></additional><is_claimable>false</is_claimable><name>Global Glomerulosclerosis and Segmental Glomerulosclerosis Could Serve as Effective Markers for Prognosis and Treatment of IgA Vasculitis With Nephritis.</name><description>&lt;b>Background:&lt;/b> This study was aimed at investigating the clinical significance and curative effect of global glomerulosclerosis (GS) and segmental glomerulosclerosis (S) in adult-onset IgA vasculitis with nephritis (IgAV-N) patients since there was no consensus pathological grading method for adult IgAV-N. &lt;b>Methods:&lt;/b> A total of 188 biopsy-proven IgAV-N patients were prospectively identified. Patients were separately assigned to GS0/GS1/GS2 group and S0/S1/S2 based on the scores of global glomerulosclerosis and segmental glomerulosclerosis (0% /0-15% />15%, respectively). &lt;b>Results:&lt;/b> GS0, GS1, and GS2 occurred in 56.4, 29.2, and 14.4% of the adult-onset IgAV-N, respectively. Patients in GS2 group tended to have the most serious renal deterioration and the highest levels of bloo</description><dates><release>2020-01-01T00:00:00Z</release><publication>2020</publication><modification>2025-04-21T19:03:34.059Z</modification><creation>2020-11-19T15:24:56Z</creation></dates><accession>S-EPMC7646400</accession><cross_references><pubmed>33195349</pubmed><doi>10.3389/fmed.2020.588031</doi></cross_references></HashMap>